`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`APOTEX, INC.,
`Petitioner,
`v.
`CELGENE CORPORATION,
`Patent Owner.
`
`
`Case IPR2023-00512
`Patent 8,846,628
`
`
`DECLARATION OF NORA Q.E. PASSAMANECK IN SUPPORT OF
`UNOPPOSED MOTION FOR ADMISSION PRO HAC VICE
`
`CELGENE 2153
`APOTEX v. CELGENE
`IPR2023-00512
`
`
`
`I, Nora Q.E. Passamaneck, declare as follows:
`1.
`I obtained a B.A. from New York University in 1998 and a J.D. from
`
`IPR2023-00512
`Patent No. 8,846,628
`
`
`the Boston University School of Law in 2003.
`
`2.
`
`I am currently a partner in the law firm of Wilmer Cutler Pickering
`
`Hale and Dorr LLP. I was admitted to the Massachusetts Bar in February 2004,
`
`the New York Bar in October 2004, and the Colorado Bar in February 2016. I
`
`have been practicing law for over 15 years. My practice has focused primarily on
`
`patent litigation. Over the course of my career, I have been counsel in numerous
`
`patent litigations.
`
`3.
`
`I am a member in good standing of the Bars of the Commonwealth of
`
`Massachusetts, State of New York, and State of Colorado. I am admitted to
`
`practice before the U.S. District Courts for the District of Colorado, District Court
`
`for the Eastern District of New York, and District Court for the Southern District
`
`of New York. I am also admitted to practice before the U.S. Court of Appeals for
`
`the Federal Circuit and the Tenth Circuit.
`
`4. My Massachusetts Bar membership number is 657723. My New
`
`York Bar membership number is 4262028. My Colorado Bar membership number
`
`is 49362.
`
`5.
`
`I have assisted in a number of IPR proceedings, including Pfizer Inc.
`
`et al. v. Genentech Inc., IPR2017-01121; Celltrion Inc. v. Genentech Inc.,
`
`
`
`- 1 -
`
`
`
`IPR2023-00512
`Patent No. 8,846,628
`
`IPR2017-01122; Hospira Inc. v. Genentech Inc., IPR2017-00731; and Hospira Inc.
`
`et al. v. Genentech Inc., IPR2017-00737.
`
`6.
`
`I have an established familiarity with the subject matter of U.S. Patent
`
`No. 8,846,628 (the ’628 patent), the ’628 patent’s file history, and the prior art at
`
`issue in this proceeding. I am familiar with pharmaceutical technologies as a
`
`result of participation as counsel in related district court litigations on the ’628
`
`patent as well as prior pharmaceutical-related intellectual property cases on behalf
`
`of Bristol-Myers Squibb Co. I have also represented other pharmaceutical
`
`companies in intellectual property matters before federal district courts.
`
`7.
`
`I have never been suspended or disbarred from practice before any
`
`court or administrative body.
`
`8.
`
`I have never had a court or administrative body deny my application
`
`for admission to practice.
`
`9.
`
`I have never had any sanctions or contempt citations imposed on me
`
`by any court or administrative body.
`
`10.
`
`I attest to each of the listed items required by the Order – Notice of
`
`Filing Date Accorded to Petition And Time For Filing Patent Owner Preliminary
`
`Response in IPR2023-00512.
`
`11.
`
`I have read and will comply with Office Patent Trial Practice Guide
`
`and the Board’s Rules of Practice for Trials, as set forth in 37 C.F.R. Part 42.
`- 2 -
`
`
`
`
`
`I agree to be subject to the United States Patent and Trademark Office
`
`IPR2023-00512
`Patent No. 8,846,628
`
`
`12.
`
`Rules of Professional Conduct set forth in 37 C.F.R. §§ 11.101 et seq. and
`
`disciplinary jurisdiction under 37 C.F.R. § 11.19(a).
`
`I hereby declare that all statements made herein of my own knowledge are
`
`true and that all statements made on information and belief are believed to be true;
`
`and further that these statements are made with the knowledge that willful false
`
`statements and the like are punishable by fine, imprisonment, or both, under
`
`Section 1001 of Title 18 of the United States Code.
`
`
`Dated: October 18, 2023
`
`
`
`
`
`
`Respectfully submitted,
`
`/Nora Q.E. Passamaneck/
`Nora Q.E. Passamaneck
`WILMER CUTLER PICKERING
` HALE AND DORR LLP
`1225 Seventeenth Street
`Suite 2600
`Denver, CO, 80202
`Nora.Passamaneck@wilmerhale.com
`Tel.: 720-274-3152
`Fax: 720-274-3133
`
`- 3 -
`
`
`
`
`
`